Metoprolosuccinat Dura (Metoprolol Tartrate)

Metoprolol works by selectively binding to β1‑adrenergic receptors in the heart, blocking the effects of adrenaline and noradrenaline. This antagonism reduces heart rate, contractile force, and conduction velocity, leading to lower cardiac output and blood pressure. It also suppresses renin release from the kidneys, further contributing to its antihypertensive action.

The appropriate dose of Metoprolosuccinat Dura is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and tolerance. Dosage may be started low and titrated upward, and adjustments are often required for renal or hepatic impairment. Patients should follow the exact regimen provided by their healthcare professional.

Safety data for metoprolol in pregnancy are limited, and the drug should only be used if the potential benefit justifies any possible risk to the fetus. It is excreted in breast milk, so caution is advised for nursing mothers, and a healthcare provider should evaluate the risk‑benefit balance before continuation during lactation.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing a formal quotation, confirming availability, shipping terms, and any necessary import documentation.

Metoprolol is a cardio‑selective β1‑blocker, offering a favorable profile for patients with respiratory conditions compared with non‑selective agents like propranolol. Compared with newer agents such as carvedilol, metoprolol has a simpler dosing schedule and fewer vasodilatory effects, but the choice of therapy depends on individual patient characteristics, comorbidities, and physician preference.

Metoprolosuccinat Dura should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed until use. Do not store in a refrigerator or freezer, as temperature extremes may affect tablet integrity.

The medication is taken orally, usually with or without food, as directed by a healthcare professional. Tablets should be swallowed whole with a glass of water and not chewed or crushed, unless specifically instructed. Consistent timing each day helps maintain stable blood levels, and patients should avoid abrupt discontinuation without medical guidance.

The most serious adverse events include severe bradycardia, heart block, marked hypotension, and bronchospasm, particularly in patients with underlying respiratory disease. These reactions can be life‑threatening and require immediate medical attention. Regular monitoring of heart rate, blood pressure, and respiratory status is essential, especially during dose adjustments or when interacting drugs are introduced.

Metoprolosuccinat Dura is contraindicated in patients with known hypersensitivity to metoprolol or any component of the formulation, those with severe sinus bradycardia, second‑ or third‑degree atrioventricular block without a pacemaker, and individuals experiencing cardiogenic shock. Caution is also advised for patients with uncontrolled asthma or severe chronic obstructive pulmonary disease, as β1‑selectivity may not fully prevent bronchoconstriction.